University of Padova, Padua, Italy, and HARVEST Study Group, Italy

Similar documents
Insulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults

Depok-Indonesia STEPS Survey 2003

The role of physical activity in the prevention and management of hypertension and obesity

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM

High intensity exercise improves cardiac structure and function and reduces liver fat in adults with Type 2 diabetes

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice

Patient is healthy with no chronic disease or significant risk factors [16%].

Implications of Drug-related Increases in Blood Pressure

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

24-uur ambulante bloeddrukmeting versus thuisbloedrukmeting

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

Conventional and Ambulatory Blood Pressure as Predictors of Retinal Arteriolar Narrowing

Declaration of conflict of interest

Analyzing diastolic and systolic blood pressure individually or jointly?

Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University

Marginal donors: Young vs. Old

Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures

Long-term Blood Pressure Variability throughout Young Adulthood and Cognitive Function in Midlife; CARDIA study

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan.

Using the New Hypertension Guidelines

Cardiovascular Risk Assessment and Management Making a Difference

Treating Hypertension in 2018: What Makes the Most Sense Today?

Know Your Number Aggregate Report Single Analysis Compared to National Averages

BackBeat Cardiac Neuromodulation Therapy (CNT) for Immediate, Substantial and Sustained Lowering of Blood Pressure. Daniel Burkhoff MD PhD

Diastolic hypertension, defined as a diastolic blood pressure

Arterial Pressure in CKD5 - ESRD Population Gérard M. London

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography

Objectives. Describe results and implications of recent landmark hypertension trials

Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

What s the evidence, why do guidelines differ, and what should the GP do?

DIFFERENTE RELAZIONE TRA VALORI PRESSORI E MASSA VENTRICOLARE SX NEI DUE SESSI IN PAZIENTI IPERTESI.

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

Magnetic resonance imaging, image analysis:visual scoring of white matter

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

Current status on other health effects:

Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex

J-curve Revisited. An Analysis of Blood Pressure and Cardiovascular Events in the Treating to New Targets (TNT) Trial

INCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS

Special Lecture 10/28/2012

Causes of Poor BP control Rates

Hypertension in the very old. Objectives: Clinical Perspective

Blood Pressure Response Under Chronic Antihypertensive Drug Therapy

Masked Hypertension and Aortic Coarctation: Impact on Ventricular Function and Morphology

a Centre d Investigations Préventives et Cliniques, b Hypertension and Received 18 July 2007 Revised 11 February 2008 Accepted 13 February 2008

KDIGO Controversies Conference on Blood Pressure in CKD

Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient

Talking about blood pressure

ORIGINAL INVESTIGATION. Prognosis of Isolated Systolic and Isolated Diastolic Hypertension as Assessed by Self-Measurement of Blood Pressure at Home

Hypertension Management Controversies in the Elderly Patient

ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*

Epidemiologic Measure of Association

Supplementary Online Content

Jared Moore, MD, FACP

Hypertension Guidelines JNC Recommendations. Robert E. Bulow DO FACOI, FACC

AGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK. Michael Smolensky, Ph.D. The University of Texas Austin & Houston

Lowering blood pressure (BP) in patients with type 2

Disclosure Information : No conflict of interest

STATE OF THE ART BP ASSESSMENT

HYPERTENSION: ARE WE GOING TOO LOW?

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

Slide notes: References:

Endothelial function is impaired in women who had pre-eclampsia

Optimal blood pressure targets in chronic kidney disease

Summary of recommendations

ORIGINAL INVESTIGATION. Blunted Heart Rate Dip During Sleep and All-Cause Mortality. clinical practice and in hypertension

Association of Arg16Gly Polymorphism of the Beta-2 Adrenergic receptor with Baroreflex Sensitivity and Indices of Autonomic Cardiovascular Modulation

AUTONOMIC FUNCTION IS A HIGH PRIORITY

Blood Pressure Monitoring in Chronic Kidney Disease

Egyptian Hypertension Guidelines

The effect of a change in ambient temperature on blood pressure in normotensives

Improved control for confounding using propensity scores and instrumental variables?

The earlier BP control the better cardiovascular outcome. Jin Oh Na Cardiovascular center Korea University Medical College

When should you treat blood pressure in the young?

Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China

HTA ET DIALYSE DR ALAIN GUERIN

Supplementary Online Content

Supplementary Material. Serum Chloride is an Independent Predictor of Mortality in Hypertensive Patients

Hypertension Guidelines 2017

Quality ID #122: Adult Kidney Disease: Blood Pressure Management National Quality Strategy Domain: Effective Clinical Care

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

Randomized Design of ALLHAT BP Trial

Arterial stiffness and central BP as goals for antihypertensive therapy in pre- and elderly. Piotr Jankowski

Blood Pressure Measurement in SPRINT

Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial

47 Hypertension in Elderly

Update on HTN and ABPM. Raj Padwal Division of General Internal Medicine University of Alberta

Individual management of arterial hypertension. Doumas Michael, Internist Lecturer, Aristotle University, Thessaloniki

2014 Evidence-Based HTN Guideline: Preliminary Data from AMGA s Anceta Collaborative

Chapter-IV. Blood pressure and heart rate variability as function of ovarian cycle in young women

Blood Pressure LIMBO How Low To Go?

Cardiovascular Diseases in CKD

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

Section 03: Pre Exercise Evaluations and Risk Factor Assessment

Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension

Blood Pressure Targets in Diabetes

Transcription:

University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini F, Fania C, Mazzer A, Casiglia E, Palatini P.

INTRODUCTION Isolated systolic hypertension (ISH) is the most common form of hypertension among young males but the clinical significance of this condition is still controversial. In a general male population, it has been shown that elevated pulse pressure has an important predictive capacity for cardiovascular disease among people 60 years, while among people <60 years of age, pulse pressure only had a marginal predictive value. One main confounding factor is the strong white-coat effect often observed in young ISH subjects

Aim of the study The aim of this study was to investigate the risk of hypertension needing pharmacological treatment in ISH of the young identified with ambulatory 24h blood pressure

* Padua *Study initiated in 1990

HARVEST Study Protocol Blood Pressure and Heart Rate Measurement 6 Clinic readings 2 visits BASELINE Stage 1 Hypertension (DBP 90-99/SBP 140-159,mmHg) 3 Clinic readings 3 Clinic readings 1 Month 2 Months 6 Clinic readings 2 visits 3 Clinic readings 3 Clinic readings 3 Months 6 Months END POINTS Hypertension needing antihypertensive treatment according to International Guidelines MACE 3 Clinic readings 6-month intervals

Subjects classification Participants were classified as having normotension (NT, N=269), ISH (N=209), DH, (N=277) or SDH (N=451) on the basis of their average 24h BP. NT was defined as a systolic BP <130 mm Hg and diastolic BP <80 mm Hg, ISH as a systolic BP > 130 mm Hg and diastolic BP<80 mm Hg, DH as a diastolic BP > 80 mm Hg and a systolic BP <130 mm Hg SDH was defined as a diastolic BP > 80 mm Hg and a systolic BP> 130 mm Hg. The 97 mmhg partition value was used to distinguish between subjects with high and with low 24h mean BP (diastolic BP + 1/3 pulse pressure).

. Baseline characteristics of 1206 study participants Variable according Normal 24h BP to hypertension ISH DH subtype. SDH P value Age, years 32.4±8.4 27.5±7.8 35.5±7.7 34.5±8.3 <0.001* Sex (M), % 69.5 89.9 59.6 74.7 <0.0001ǂ BMI, kg/m 2 25.0±3.7 25.3±2.9 25.7±3.7 25.5±3.2 0.20 Smokers, % 17.8 24.4 17.0 23.9 0.043ǂ Active in sports, % 28.2 35.4 15.9 21.1 <0.0001ǂ SBP, mmhg 143.3±9.9 147.9±11.4 142.6±10.0 147.4±10.2 <0.001 DBP, mmhg 92.0±6.0 90.5±6.3 94.7±4.8 95.1±5.0 <0.001 PP, mmhg 51.3±10.7 57.3±12.8 47.9±9.6 52.3±9.9 <0.001 HR, bpm 75.7±9.3 73.1±9.8 75.7±10.1 74.0±9.2 0.018 24-h SBP, mmhg 120.0±7.0 137.4±5.7 123.4±5.1 139.6±7.4 <0.001 24-h DBP, mmhg 73.6±5.4 73.8±5.4 84.8±3.8 87.9±5.3 <0.001 24-h MBP, mmhg 89.1±4.5 95.0±4.0 97.7±3.4 105.1±4.8 <0.001 24-h PP, mmhg 46.3±8.3 63.7±8.2 38.6±5.5 51.7±7.8 <0.001 24-h HR, mmhg 71.7±8.2 69.9±7.5 75.1±7.8 73.6±8.1 <0.001 SBP dip, % 13.0±5.9 12.9±6.9 12.2±6.2 12.4±6.5 0.27 DBP dip, % 13.8±7.7 12.4±9.0 14.3±6.8 13.6±7.4 0.26 HR dip, % 16.3±8.3 17.3±8.8 16.0±7.7 16.1±8.1 0.84 Data are mean±sd. P values are adjusted for age and sex. * adjusted for sex; ǂ unadjusted; ISH indicates isolated systolic hypertension; DH, isolated diastolic hypertension; SDH, systolic-diastolic hypertension; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; MBP, mean blood pressure; PP pulse pressure; HR, heart rate; BP Dip, nocturnal blood pressure decline; HR Dip, nocturnal heart rate decline; WCE, white-coat effect.

ml Baseline hemodynamic variables in 826 study participants according to hypertension subtype 100 80 60 40 20 0 stroke volume P=0.017 76.9 82.8 76.3 80.7 L/min/m 2 5 4 3 2 1 0 cardiac index 3.1 3.1 3 3.1 NT ISH DH SDH mmhg/l/min/m 2 40 30 20 10 0 TPR P<0.001 30.1 31.9 33.8 35.2 NT ISH DH SDH Data are mean±sem and are adjusted for age and sex. ISH indicates isolated systolic hypertension; DH, isolated diastolic hypertension; SDH, systolic-diastolic hypertension; BP, blood pressure.

Frequency of incident hypertension needing pharmacological treatment during a 11.5 year follow-up in 1206 study participants according to hypertension subtype. NT indicates subjects with normal 24h mean blood pressure; ISH, isolated systolic hypertension; DH, isolated diastolic hypertension; SDH, systolic-diastolic hypertension

Frequency of high 24h mean blood pressure ( 97 mmhg) in 1206 study participants according to hypertension subtype NT indicates subjects with normal 24h mean blood pressure; ISH, isolated systolic hypertension; DH, isolated diastolic hypertension; SDH, systolic-diastolic hypertension.

Adjusted hazard ratios for hypertension needing pharmacological treatment in 1206 study participants grouped according to hypertension subtype. Subjects with isolated systolic hypertension and isolated diastolic hypertension were further divided into two groups with low ( 97 mmhg) or high ( 97 mmhg) 24h mean blood pressure. The risk was calculated from a multivariable Cox regression also including age, gender, body mass index, 24h heart rate, parental history for hypertension, lifestyle factors, serum glucose, total cholesterol, systolic and diastolic blood pressure white-coat effects, and systolic blood pressure, diastolic blood pressure, and heart rate nocturnal dips. NT indicates subjects with normal 24h mean blood pressure; ISH, isolated systolic hypertension; DH, isolated diastolic hypertension; SDH, systolic-diastolic hypertension

CONCLUSIONS The present data show that in young individuals ISH identified with ambulatory BP monitoring does not imply a higher risk of developing hypertension needing treatment in later life. 24-hour mean BP is the main predictor of future hypertension in this age range.